Evidence map›Paper›PMID 38515401›Full record

ArticleDrug delivery2024

Backflow reduction in local injection therapy with gelatin formulations.

Kazuki Kotani, Francois Marie Ngako Kadji, Yoshinobu Mandai, Yosuke Hiraoka

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kazuki KotaniDepartment of Biomedical, R&D C-enter, Nitta Gelatin, Inc, Yao City, Osaka, Japan.
Francois Marie Ngako KadjiDepartment of Biomedical, R&D C-enter, Nitta Gelatin, Inc, Yao City, Osaka, Japan.
Yoshinobu MandaiDepartment of Biomedical, R&D C-enter, Nitta Gelatin, Inc, Yao City, Osaka, Japan.
Yosuke HiraokaDepartment of Biomedical, R&D C-enter, Nitta Gelatin, Inc, Yao City, Osaka, Japan.
Getty Research Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The local injection of therapeutic drugs, including cells, oncolytic viruses and nucleic acids, into different organs is an administrative route used to achieve high drug exposure at the site of action. However, after local injection, material backflow and side effect reactions can occur. Hence, this study was carried out to investigate the effect of gelatin on backflow reduction in local injection. Gelatin particles (GPs) and hydrolyzed gelatin (HG) were injected into tissue models, including versatile training tissue (VTT), versatile training tissue tumor-in type (VTT-T), and broiler chicken muscles (BCM), using needle gauges between 23 G and 33 G. The backflow material fluid was collected with filter paper, and the backflow fluid rate was determined. The backflow rate was significantly reduced with 35 μm GPs (

Indexed as

GelatinNeoplasmsAnimalsChickensDrug Delivery SystemsInjectionsGelatinbackflowgelatin particleshydrolyzed gelatinLocal injection

Identifiers

PMID38515401
PMCPMC10962293
OpenAlexW4393090926

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.